Other loss of function studies showed that KCNQ1OT1 is required for cell proliferation and survival and that loss of KCNQ1OT1 promotes cell differentiation in AML cells, a feature which makes it attractive as a therapeutic target for this type of leukemia (131). The gene discussed is KCNQ1OT1; the disease is leukemia.